πŸ‡ΊπŸ‡Έ FDA
Patent

US 7989456

Pyrazine kinase inhibitors

granted A61PA61P11/06A61P25/00

Quick answer

US patent 7989456 (Pyrazine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P11/06, A61P25/00, A61P29/00, A61P35/00